IBM stock has performed poorly over the years as the company's two key metrics - revenue and free cash flow - stagnate. That's all water under the bridge as IBM has reinvented themselves now with (checks notes) yet another pivot into AI. IBM's AI creation Watson is now watsonx, and that subtle name change is supposed to make us forget about the Watson Health disaster. Based on comments in the latest earnings call, generative AI and Watson brought in $400 million in revenues last quarter, but that will be recognized over 12-24 months. In the meantime, the "Data and AI" revenue segment grew just 5% last year. IBM is no AI stock, but they are forecasting $12 billion in free cash flow next year which saw their share price hit 10-year highs. Now maybe they can start growing that dividend a bit more than just the paltry 1.3% we've seen over the past 5 years. Here's to hoping we're wrong about IBM's AI success story being all dough and little show.


Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/VCPitfzj5oQ.

Ver todos los episodios